Review Wed December 31
Sometimes, I'll wake up and go to my office with a protein drink and lemon water
In our review, we summarize evidence from randomized clinical trials and meta-analyses showing that ten approved and emerging obesity medications can improve a remarkably broad range of obesity-related conditions, including: Liver disease (MASLD and MASH) Chronic kidney disease PCOS (now increasingly referred to as PMOS, polyendocrine metabolic-ovarian syndrome) Obstructive sleep apnoea Osteoarthritis and physical functioning Cardiovascular disease Prediabetes and type 2 diabetes Importantly, many of these benefits are related to weight loss itself
Dsip peptide Details Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide first isolated from the cerebral venous blood of rabbits during induced delta-wave (slow-wave) sleep, and subsequently identified in human cerebrospinal fluid
These benefits appear to be related, in part, to enhanced recruitment of collateral circulation, which supports oxygen delivery to compromised cardiac tissue
K., & Esteban-Cruciani, N